MB:MILMediobanca - Banca di Credito Finanziario S.p.A. Analysis
Data as of 2026-06-11 - not real-time
€24.61
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mediobanca is trading at €24.61, just below the calculated resistance of €25.54 and comfortably above the 20‑day SMA of €21.74, indicating a bullish short‑term trend. However, the RSI is perched at 76, signaling an overbought condition, and the recent Q1 earnings miss (net income €322.7 million vs €334 million a year ago) nudged the stock down 1.1% on the day. Operating margins of 54% and a profit margin of 39% underline strong profitability, while the PE of 16.7 is roughly in line with the industry average of 16.5, suggesting a fair valuation despite the price being above analyst target levels. The dividend yield remains attractive at 5.05% with a payout ratio of 78%, supported by a hefty cash pile of €26.4 billion, making the dividend appear sustainable.
Looking ahead, the low beta of 0.38 points to limited price volatility relative to the market, but a 30‑day volatility of 39% and a max drawdown of 30% highlight notable downside risk. The stock’s solid dividend, robust operating performance, and bullish technical signals favor a medium‑ to long‑term buy stance, while the overbought RSI and proximity to resistance advise a cautious hold in the near term.
Looking ahead, the low beta of 0.38 points to limited price volatility relative to the market, but a 30‑day volatility of 39% and a max drawdown of 30% highlight notable downside risk. The stock’s solid dividend, robust operating performance, and bullish technical signals favor a medium‑ to long‑term buy stance, while the overbought RSI and proximity to resistance advise a cautious hold in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Price near resistance level
- Recent earnings miss
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and SMA alignment
- High dividend yield with strong cash base
- Operating margins above 50%
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend payout
- Low beta indicating defensive profile
- Consistent profitability and fair valuation
Key Metrics & Analysis
Financial Health
Revenue Growth0.50%
Profit Margin39.08%
P/E Ratio16.7
P/B Ratio1.7
Industry P/E16.5
Technical Analysis
TrendBullish
RSI76.3
Support€20.32
Resistance€25.54
MA 20€21.74
MA 50€20.16
MA 200€18.34
MACDBullish
VolumeIncreasing
Fear & Greed Index81.75
Valuation
Target Price€21.77
Upside/Downside-11.53%
GradeFair
TypeBlend
Dividend Yield5.05%
Risk Assessment
Beta0.39
Volatility39.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.